Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Radiotheranostics Market?
In recent times, the market size of radiotheranostics has witnessed rapid growth. This market will witness growth from $8.79 billion in 2024 to a substantial $10.05 billion by 2025, marking a compound annual growth rate (CAGR) of 14.4%. The growth seen in the historical period is largely due to advancements in nuclear medicine, an increasing number of cancer cases, development in personalized medicine, strides in radiopharmaceuticals, as well as regulatory approvals and standards.
The market size for radiotheranostics is anticipated to experience a swift expansion in the coming years. Its growth projection is estimated at $16.87 billion by 2029, marking a compound annual growth rate (CAGR) of 13.8%. Factors contributing to this predicted surge during the forecast period include progress in targeted cancer treatments, increased research in the oncology field, a rise in chronic diseases, and the development of theranostic applications. The forecast period also forecasts trends such as the evolution of theranostic radiopharmaceuticals, increasing applications beyond the field of oncology, personalized radiopharmaceuticals, the use of nanotechnology in radiotheranostics, and changes in regulatory norms and standardization.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12270&type=smp
Which Industry Forces Are Driving The Radiotheranostics Market Forward?
The rising incidence of cancer is anticipated to fuel the expansion of the radiotheranostics market. Cancer is a disease wherein certain body cells grow without control and migrate to other body parts. Radiotheranostics drugs are often used in cancer treatment to provide the ultimate personalized medical solution. They utilize tandem diagnostic and radioisotope therapy probes for the targeted detection and treatment of specific cells, typically cancerous ones, each tailored to suit the patient’s unique condition. This approach improves treatment effectiveness and results in better patient outcomes. For example, the American Cancer Society, a nonprofit US-based cancer advocacy group, reported in January 2024 that the cancer incidence escalated to 2,001,140 as compared to 1,958,310 in 2023, showing a 2.19% increase. Thus, the escalating incidence of cancer propels the drive for the radiotheranostics market.
How Is The Radiotheranostics Market Organized By Different Segments?
The radiotheranosticsmarket covered in this report is segmented –
1) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; Fludeoxyglucose-18F; Yttrium-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioisotopes
2) By Approach: Targeted Therapeutic; Targeted Diagnostic
3) By Application: Oncology; Non-Oncology
4) By End-Users: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Technetium-99: Technetium-99m; Technetium-99 Pertechnetate
2) By Gallium-68: Gallium-68 DOTATATE; Gallium-68 PSMA
3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment; Iodine-131 For Hyperthyroidism Treatment
4) By Iodine-123: Iodine-123 For Thyroid Scans; Iodine-123 For Cardiac Imaging
5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging; FDG For Brain Imaging
6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer; Yttrium-90 For Radioimmunotherapy
7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer; Lutetium-177 DOTATATE For Neuroendocrine Tumors
8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy; Copper-67 In Clinical Trials
9) By Copper (Cu) 64: Copper-64 For PET Imaging; Copper-64 For Radiotherapy
10) By Other Radioisotopes: Radium-223; Samarium-153; Other Emerging Radioisotopes In Theranostics
What Current And Upcoming Trends Are Shaping The Radiotheranostics Market?
One of the prominent trends observed in the radiotheranostics market is the emergence of product innovations. Major players in the market are focusing on developing innovative products to solidify their market presence. For example, in May 2023, Advanced Cyclotron Systems Inc., a company from Canada that specializes in supplying and servicing cyclotrons used principally for the production of medical isotopes, launched TR-ALPHA. This product is designed for the production of cancer-curing alpha-emitting radioisotopes, addressing the market’s need for a low-cost yet high-production cyclotron. Astatine-211, one of the most effective alpha-emitting radioisotopes, can be produced in large quantities with TR-ALPHA. Furthermore, TR-ALPHA is not only smaller, less expensive, and easier to operate than previous cyclotrons capable of producing alpha-emitting radioisotopes but is also a perfect solution for hospitals, researchers, and institutions that require a dedicated cyclotron to produce large quantities of therapeutic alpha-emitting radioisotopes efficiently.
Who Are The Primary Market Leaders In The Radiotheranostics Market?
Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/radiotheranostics-global-market-report
How Do Regional Dynamics Influence The Radiotheranostics Market Performance?
North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12270&type=smp
Browse Through More Reports Similar to the Global Radiotheranostics Market 2025, By The Business Research Company
Cardiac Assist Devices And Equipment Global Market Report 2025
White Goods Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/white-goods-global-market-report
Food Service Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/food-service-equipment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model